Daily antibiotic cost of nosocomial infections in a Turkish university hospital

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Inan, Dilara ^a   Saba, Rabin ^a   Gunseren, Filiz ^a   Ongut, Gozde ^a   Turhan, Ozge ^a   Yalcin, Ata Nevzat ^a   Mamikoglu, Latife ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; NETILMICIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; TIMENTIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CALCULATION; DRUG COST; DRUG USE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SURGICAL INFECTION; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL; URINARY TRACT INFECTION;

EID: 25444438247     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-5     Document Type: Article

References (17)

1. Jarvis WR: Selected aspects of socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996, 17:552-557.
2. Zoutman D, McDonald S, Vethanayagan D: Total and attributable costs of surgical-wound infections at a Canadian tertiarycare center. Infect Control Hosp Epidemiol 1998, 19:254-259.
3. Plowman R, Graves N, Griffin MAS, Roberts JA, Swan AV, Cookson B, Taylor L: The rate and cost of hospital acquired infections occurring in patients addmitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001, 47:198-209.
4. Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ: Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect 2001, 47:223-229.
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections. Am J Infect Control 1988, 16:128-140.
6. Horan TC, Gaynes RP, Martone WY, Jarvis WR, Emori TG: CDC definitions of nosocomial surgical site infections. 1992: A modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992, 13:606-608.
7. Haley RW, Schaberg DR, Van Allmen SD, Mc Gowen JE: Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980, 141:248-257.
8. Yalcin AN, Hayran M, Unal S: Economic analysis of nosocomial infections in a Turkish University Hospital. J Chemother 1997, 9:411-414.
9. Andersen BM: Economic consequences of hospital infections in a 1000 bed university hospital in Norway. Infect Control Hosp Epidemiol 1998, 19:805-807.
10. Kerr JR, Borr JG, Smyth ETM, O'Hare J: Technique for calculation of the true costs of antibiotic therapy. Eur J Clin Microbiol Infect Dis 1992, 11:823-827.
11. Astagneau P, Fleury L, Leroy S, Lucet JC, Golliot F, Regnier B, Brucker G: Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey. J Hosp Infect 1999, 42:303-312.
12. French GL, Cheng AFB: Measurement of the costs of hospital infection by prevalence surveys. J Hosp Infect 1991:65S-72S.
13. Haley RW: Measuring the costs of nosocomial infections: methods for estimating the economic burden on the hospital. Am J Med 1991:32S-38S.
14. Yalcin AN, Turgut H, Cetin CB, Tefci F: Cost of antimicrobial therapy in nosocomial infections [In Turkish]. Turkish Journal of Hospital Infection 2002, 6:41-45.
15. Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, Cooke EM: The cost of infection in surgical patients: a case-control study. J Hosp Infect 1993, 25:239-250.
16. Carmeli Y, Troillet N, Karchmer AW, Samore MH: Pseudomonas aeruginosa: health and economic impact of antibiotic resistance and emergence of resistance. Arch Intern Med 1999, 159:1127-1132.
17. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP, Hooton TM: The efficacy of infection surveillance and control programs in preventing nosocomial infections in US Hospitals. Am J Epidemiol 1985, 121:182-205.